Tianjin Lisheng Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 911.57 million compared to CNY 902.02 million a year ago. Revenue was CNY 911.57 million compared to CNY 902.02 million a year ago.

Net income was CNY 342.67 million compared to CNY 112.62 million a year ago. Basic earnings per share from continuing operations was CNY 1.86 compared to CNY 0.62 a year ago. Diluted earnings per share from continuing operations was CNY 1.86 compared to CNY 0.62 a year ago.